Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 03:30 ET | Source: Synklino

Synklino announces first patient dosed in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation

Synklino announces treatment of first patient in Phase 1 trial of SYN002 for CMV prevention in kidney transplantation.
February 25, 2026 03:30 ET | Source: Synklino

Synklino announces publication in American Journal of Transplantation highlighting proof-of-concept for SYN002 in eliminating CMV in human kidneys

Synklino, publishes data in the American Journal of Transplantation and will present this as a poster at the Cutting Edge of Transplantation (CEoT) Summit.